Evidence map›Paper›PMID 31386861›Full record

ReviewDevelopmental cell2019

The Hippo Signaling Pathway in Development and Disease.

Yonggang Zheng, Duojia Pan

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Developmental cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07759466 (Hippo Signaling Pathway Proteins and Their Correlation With Markers of Apoptosis and Bone Metabolism in the Gingival Crevicular Fluid of Individuals With Periodontal Disease), which is not on this map. Cited by 545 papers.

0numbers the graph read from it
0cells of the map it votes in
545citing papers in PubMed
48.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07759466 completednot on this mapstarted 2024, after this paper: background citation

Hippo Signaling Pathway Proteins and Their Correlation With Markers of Apoptosis and Bone Metabolism in the Gingival Crevicular Fluid of Individuals With Periodontal Disease

TypeobservationalSponsorInonu UniversityRan2024 to 2025Enrolled75ConditionsPeriodontal Disease, Gingivitis and Periodontal Diseases, Biomarker Discovery and Validation, PathwaysArmsELISA Biomarker Analysis
3 · Its place in the literature

Who cites it

545 citing papers in PubMed, 908 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

485 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yonggang ZhengDepartment of Physiology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-9040, USA.
Duojia PanDepartment of Physiology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-9040, USA. Electronic address: duojia.pan@utsouthwestern.edu.
Southwestern Medical Center · US

Funding

Control of Cell Number in Developing RetinaR01EY015708 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI DUOJIA PAN · 2004 to 2026
$8.8M
Howard Hughes Medical InstituteNEI NIH HHS R01 EY015708
6 · The paper itself

Abstract

The Hippo signaling pathway regulates diverse physiological processes, and its dysfunction has been implicated in an increasing number of human diseases, including cancer. Here, we provide an updated review of the Hippo pathway; discuss its roles in development, homeostasis, regeneration, and diseases; and highlight outstanding questions for future investigation and opportunities for Hippo-targeted therapies.

Indexed as

Gene Expression Regulation, DevelopmentalSignal TransductionAnimalsCell Cycle ProteinsExosome Multienzyme Ribonuclease ComplexHumansNeoplasmsTranscription FactorsCell Cycle ProteinsDIS3 protein, humanExosome Multienzyme Ribonuclease ComplexTranscription FactorsYY1AP1 protein, humanactomyosinadherens junctioncancercell polaritycytoskeletongrowth controlhippo signalingmechanotransductionmerlinneurofibromatosisNF2oncogeneregenerationscallopedspectrinTAZTEADtissue homeostasistumor suppressorYAPyorkie

Identifiers

PMID31386861
PMCPMC6748048
OpenAlexW2966798736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.